Skip to main content
Loading

Careful selection of building block properties and compatibility essential to boost overall success of multispecifics

28 Apr 2026
Formats & Scaffolds
  • What is the minimum of sdAb architecture we have to try?
  • How to efficiently link the screening of binding and functionality?
  • How to mitigate the potential risk of reduced colloidal stability, increased aggregation and off target effect associated with higher valency?
Industry Expert
Tao Wang, VP of Product Discovery and Boston Site Head - Crossbow Therapeutics